• Will younger, healthier individuals under 40 purchase health insurance or will they choose to wait to buy coverage after they need medical services?

    -  Karen Ignagni
  • Will the government be able to create a viable, long-term solution to the Sustainable Growth Rate (SGR) payment model?

    -  Martin P. Hauser
  • We don’t really know what impact the introduction of premium and cost-sharing subsidies will have on the larger conversation about government entitlements.

    -  Barbara Morales Burke
  • We’re not sure consumers are ready for reform — even people who are uninsured.

    -  Dan Hilferty
  • We don’t know how much churning will go on between Medicaid and the exchanges.

    -  Margaret Murray
  • What kind of latitude do employers feel they have as far as altering their employee health benefits?

    -  Vik Mangalmurti
  • One of the biggest unknowns…is whether we will see the appearance of a paradigm changing, low-cost, great service, health plan.

    -  Don Hall
  • We don’t know whether there will be enough primary care providers (PCPs) to accommodate the 32 million-plus individuals who will now have health insurance.

    -  Joel Brill, MD
  • There are many more things about the future that we do not know than there are those we do know.

    -  Jim Fox
  • Can payers and providers grow to trust each other quickly?

    -  Bill Fera, MD
  • One of the biggest unknowns will be the impact and cost of serving new customers under health insurance exchanges.

    -  Rebecca L. Ditmer
  • The biggest unknown related to ACOs is, of course, how successful will ACOs be in improving value to their attributed populations…

    -  Scott W. Van Valkenburg, MD
  • Will health plans' market share get so watered down they can no longer negotiate with providers?

    -  Bill Copeland
  • Healthcare technology has to enable more immediate consumer access to data.

    -  Liam Walsh
  • How many states will expand Medicaid eligibility up to 133% of the FPL?

    -  John Meerschaert, FSA, MAAA
  • What are the likely drug utilization patterns and financial impact for the millions of individuals soon to be accessing care through the exchanges?

    -  David Calabrese
  • We have absolutely no clue how many companies are going to move to the exchanges.

    -  Al Lewis
  • We don’t know the true costs on the U.S. healthcare system of expanding access to Americans.

    -  Perry Cohen
  • Will PPACA have an adverse effect on the productivity of U.S. employees, an unintended consequence?

    -  Kathy Prosser
  • Our largest "unknown" concerning meaningful use and electronic medical records (EMRs) pertains to the CMS audits that have just begun by Figloiozzi and Company.

    -  Tamara M. O’Reilly